Gilead Sciences, Inc.
HBV VACCINES AND METHODS TREATING HBV
Last updated:
Abstract:
Provided are HBV immunogenic polypeptides, polynucleotides encoding such polypeptides, vectors expressing such immunogenic polypeptides for use in eliciting an immune response against HBV; pharmaceutical and immunogenic compositions and kits comprising such polypeptides, polynucleotides or vectors, and methods of use in treating and/or preventing HBV.
Status:
Application
Type:
Utility
Filling date:
28 Sep 2020
Issue date:
1 Apr 2021